CEO Arnon Rosenthal was paid $1,995,018 in fiscal year 2025, ↓ down 45.6% from fiscal year 2024, the 75th percentile of its disclosed peer group (SEC filing 0001193125-26-186928 ↗): executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.
$1,995,018 ↓ Arnon Rosenthal total, FY2025 | 75th CEO pay percentile vs peers | — CEO-to-median pay ratio | 95.91% Say-on-pay support, latest vote |
Track this company's pay every filing: join the Pro seat waitlist
Velarion Pro: every company page, peer tools and exports, one seat — $1,200/year
Ask our research desk — $99, 24h, every figure cited to its filing.
ALEC's next annual pay disclosure, estimated May 2, 2027.est. Filing ↗
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Arnon Rosenthal | $678,100 | $0 | $422,876 | $558,216 | $325,488 | $0 | $10,338 | $1,995,018 |
| Co-founder, Chief Executive Officer, and Director | ||||||||
| Sara Kenkare-Mitra | 614,301 | 0 | 77,710 | 17,810 | 314,200 | 0 | 551,129 | 1,575,150 |
| Former President and Head of Research and Development | ||||||||
| Neil Berkley | 455,000 | 91,000 | 128,135 | 219,202 | 152,880 | 0 | 6,242 | 1,052,459 |
| Chief Financial Officer and Chief Business Officer | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
| Named executive officer | FY2025 total | FY2024 total | FY2023 total | Δ FY2024→2025 |
|---|---|---|---|---|
| Arnon Rosenthal | $1,995,018 | $3,666,341 | $4,255,007 | ↓ −1,671,323 |
| Sara Kenkare-Mitra | 1,575,150 | 2,549,681 | 2,606,214 | ↓ −974,531 |
| Neil Berkley | 1,052,459 | — | — | — |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
You have just read Alector's Summary Compensation Table. The whole free brief as a PDF, emailed now, with every figure cited — then a few short notes on the deeper ALEC reports.
We send the PDF right away, then up to three short notes. Reply “unsubscribe” to any of them, any time.
How we handle your data → Privacy
Each company listed discloses ALEC in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named ALEC in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.
One page per director: the seat, the committees and the fee table, read for one person at a time.
| Director | Role | FY2025 total |
|---|---|---|
| David Wehner | Independent Director | $29,107 |
| Elizabeth Garofalo | Independent Director | $117,442 |
| Errol De Souza | Independent Director | $119,942 |
| Kristine Yaffe | Independent Director | $112,442 |
| Mark Altmeyer | Independent Director | $122,964 |
| Paula Hammond | Independent Director | $114,942 |
| Richard H. Scheller | Independent Director | $223,025 |
Every insider equity transaction reported on Form 4 after the 2025 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.
| Insider | Role | Transaction date | Code | Shares | Price | Value | Security | Source |
|---|---|---|---|---|---|---|---|---|
| Richard H. Scheller | Director | 2026-06-01 | A | 10,833 | $0 | $0 | Common | Form 4 ↗ |
| Arnon Rosenthal | Director | 2026-06-02 | D | 87,216 | 2 | 172,191 | Common | Form 4 ↗ |
| Neil Berkley | CFO & Chief Business Officer | 2026-06-02 | D | 19,360 | 2 | 38,221 | Common | Form 4 ↗ |
| Grace Wong-Sarad | Principal Accounting Officer | 2026-06-02 | D | 5,709 | 2 | 11,271 | Common | Form 4 ↗ |
| Grace Wong-Sarad | Principal Accounting Officer | 2026-06-03 | D | 3,475 | 2 | 6,543 | Common | Form 4 ↗ |
| Mark Altmeyer | Director | 2026-06-17 | A | 28,700 | 0 | 0 | Common | Form 4 ↗ |
| Elizabeth Garofalo | Director | 2026-06-17 | A | 9,450 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Paula Hammond | Director | 2026-06-17 | A | 28,700 | 0 | 0 | Common | Form 4 ↗ |
| Richard H. Scheller | Director | 2026-06-17 | A | 9,450 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Richard H. Scheller | Director | 2026-06-17 | A | 28,700 | 0 | 0 | Common | Form 4 ↗ |
| Kristine Yaffe | Director | 2026-06-17 | A | 9,450 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Louis J. Lavigne Jr | Director | 2026-06-17 | A | 28,700 | 0 | 0 | Common | Form 4 ↗ |
| Louis J. Lavigne Jr | Director | 2026-06-17 | A | 9,450 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Errol B. Desouza | Director | 2026-06-17 | A | 9,450 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Errol B. Desouza | Director | 2026-06-17 | A | 28,700 | 0 | 0 | Common | Form 4 ↗ |
| Mark Altmeyer | Director | 2026-06-17 | A | 9,450 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Elizabeth Garofalo | Director | 2026-06-17 | A | 28,700 | 0 | 0 | Common | Form 4 ↗ |
| Paula Hammond | Director | 2026-06-17 | A | 9,450 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Kristine Yaffe | Director | 2026-06-17 | A | 28,700 | 0 | 0 | Common | Form 4 ↗ |
| Grace Wong-Sarad | Principal Accounting Officer | 2026-07-09 | A | 20,000 | 0 | 0 | Common | Form 4 ↗ |
| Arnon Rosenthal | Director | 2026-08-19 | A | 350,000 | 0 | 0 | Common | Form 4 ↗ |
| Arnon Rosenthal | Director | 2026-08-19 | A | 350,000 | 0 | 0 | Common | Form 4 ↗ |
| Arnon Rosenthal | Director | 2026-08-19 | A | 350,000 | 0 | 0 | Common | Form 4 ↗ |
| Arnon Rosenthal | Director | 2026-08-19 | D | 1,050,000 | 0 | 0 | Common | Form 4 ↗ |
| Grace Wong-Sarad | Principal Accounting Officer | 2026-09-02 | D | 656 | 3 | 1,804 | Common | Form 4 ↗ |
| Grace Wong-Sarad | Principal Accounting Officer | 2026-09-03 | D | 5,165 | 3 | 13,767 | Common | Form 4 ↗ |
| Arnon Rosenthal | Director | 2026-09-03 | D | 72,606 | 3 | 193,473 | Common | Form 4 ↗ |
| Neil Berkley | CFO & Chief Business Officer | 2026-09-03 | D | 29,251 | 3 | 77,948 | Common | Form 4 ↗ |
| Grace Wong-Sarad | Principal Accounting Officer | 2026-09-04 | D | 3,625 | 3 | 9,094 | Common | Form 4 ↗ |
| Arnon Rosenthal | Director | 2026-10-13 | A | 132,500 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Arnon Rosenthal | Director | 2026-10-13 | D | 132,500 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Arnon Rosenthal | Director | 2026-10-13 | A | 119,446 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Arnon Rosenthal | Director | 2026-10-13 | D | 119,446 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Arnon Rosenthal | Director | 2026-10-13 | A | 417,213 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Arnon Rosenthal | Director | 2026-10-13 | D | 417,213 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Arnon Rosenthal | Director | 2026-10-13 | A | 457,038 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Arnon Rosenthal | Director | 2026-10-13 | D | 457,038 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Arnon Rosenthal | Director | 2026-10-13 | A | 520,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Arnon Rosenthal | Director | 2026-10-13 | D | 520,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Arnon Rosenthal | Director | 2026-10-13 | D | 275,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Arnon Rosenthal | Director | 2026-10-13 | A | 500,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Arnon Rosenthal | Director | 2026-10-13 | D | 500,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Arnon Rosenthal | Director | 2026-10-13 | A | 275,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Grace Wong-Sarad | Principal Accounting Officer | 2026-10-13 | A | 11,309 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Grace Wong-Sarad | Principal Accounting Officer | 2026-10-13 | D | 11,309 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Grace Wong-Sarad | Principal Accounting Officer | 2026-10-13 | A | 11,552 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Grace Wong-Sarad | Principal Accounting Officer | 2026-10-13 | D | 11,552 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Grace Wong-Sarad | Principal Accounting Officer | 2026-10-13 | A | 10,228 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Grace Wong-Sarad | Principal Accounting Officer | 2026-10-13 | D | 10,228 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Grace Wong-Sarad | Principal Accounting Officer | 2026-10-13 | A | 20,454 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Grace Wong-Sarad | Principal Accounting Officer | 2026-10-13 | D | 20,454 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Grace Wong-Sarad | Principal Accounting Officer | 2026-10-13 | A | 13,842 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Grace Wong-Sarad | Principal Accounting Officer | 2026-10-13 | D | 13,842 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Grace Wong-Sarad | Principal Accounting Officer | 2026-10-13 | A | 20,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Grace Wong-Sarad | Principal Accounting Officer | 2026-10-13 | D | 20,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Arnon Rosenthal | Director | 2026-10-14 | A | 217,500 | 0 | 0 | Common | Form 4 ↗ |
| Arnon Rosenthal | Director | 2026-10-14 | A | 978,750 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Neil Berkley | CFO & Chief Business Officer | 2026-10-14 | A | 190,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Neil Berkley | CFO & Chief Business Officer | 2026-10-14 | A | 44,567 | 0 | 0 | Common | Form 4 ↗ |
| Grace Wong-Sarad | Principal Accounting Officer | 2026-10-14 | A | 83,435 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Grace Wong-Sarad | Principal Accounting Officer | 2026-10-14 | A | 55,555 | 0 | 0 | Common | Form 4 ↗ |
Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.
| Executive | Award | Grant date | Threshold | Target | Granted | Maximum | Grant-date fair value |
|---|---|---|---|---|---|---|---|
| Neil Berkley | OPTION | 2025-11-10 | — | — | 195,000 | — | $191,685 |
| Neil Berkley | RSU | 2025-05-15 | — | — | 38,900 | — | 42,985 |
| Arnon Rosenthal | OPTION | 2025-11-10 | — | — | 522,500 | — | 513,618 |
| Sara Kenkare | RSU | 2025-07-01 | — | — | 54,725 | — | 77,710 |
| Arnon Rosenthal | OPTION | 2025-07-01 | — | — | 45,700 | — | 44,598 |
| Arnon Rosenthal | RSU | 2025-11-10 | — | — | 174,167 | — | 228,159 |
| Arnon Rosenthal | RSU | 2025-07-01 | — | — | 137,125 | — | 194,717 |
| Neil Berkley | OPTION | 2025-07-01 | — | — | 18,000 | — | 17,566 |
| Neil Berkley | OPTION | 2025-05-15 | — | — | 12,975 | — | 9,951 |
| Sara Kenkare | OPTION | 2025-07-01 | — | — | 18,250 | — | 17,810 |
| Neil Berkley | RSU | 2025-11-10 | — | — | 65,000 | — | 85,150 |
| Named executive officer | Time-vested (RSU) | Performance-vested (PSU) | Options / SARs | % performance-vested |
|---|---|---|---|---|
| Neil Berkley | $128,135 | $0 | $219,202 | 0.0% |
| Arnon Rosenthal | 422,876 | 0 | 558,216 | 0.0% |
| Sara Kenkare | 77,710 | 0 | 17,810 | 0.0% |
% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Arnon Rosenthal | RSU | 356,127 | — | $555,558 |
| Arnon Rosenthal | RSU | 159,654 | — | 249,060 |
| Neil Berkley | RSU | 100,000 | — | 156,000 |
| Arnon Rosenthal | RSU | 99,401 | — | 155,066 |
| Neil Berkley | RSU | 95,982 | — | 149,732 |
| Arnon Rosenthal | RSU | 68,563 | — | 106,958 |
| Neil Berkley | Option | 5,407 | 1.11 | — |
| Neil Berkley | RSU | 59,584 | — | 92,951 |
| Neil Berkley | RSU | 9,725 | — | 15,171 |
| Arnon Rosenthal | Option | 24,885 | 9.46 | — |
| Arnon Rosenthal | Option | 60,730 | 6.48 | — |
| Arnon Rosenthal | Option | 26,659 | 1.42 | — |
| Arnon Rosenthal | Option | 511,615 | 1.31 | — |
| Neil Berkley | Option | 10,500 | 1.42 | — |
| Neil Berkley | Option | 190,938 | 1.31 | — |
Our executive compensation program is designed to attract, engage, and retain highly qualified executives while incentivizing achievement of our corporate strategic objectives.
| CEO STI target (% of salary) | — |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | Pearl Meyer & Partners, LLC |
| Clawback policy | true |
| Anti-hedging | — |
| Anti-pledging | — |
| Meeting year | Meeting date | For | Against | Abstain | Support | Outcome |
|---|---|---|---|---|---|---|
| 2026 | 2026-06-17 | 58,652,335 | 2,492,538 | 11,082 | 95.91% | Passed |
| 2025 | 2025-06-11 | 68,738,538 | 1,141,227 | 136,670 | 98.17% | Passed |
| 2024 | 2024-06-12 | 72,009,466 | 858,589 | 60,804 | 98.74% | Passed |
| 2023 | 2023-06-14 | 58,053,865 | 3,397,559 | 143,263 | 94.25% | Passed |
| 2022 | 2022-06-16 | 62,031,465 | 1,137,494 | 39,614 | 98.14% | Passed |
| 2021 | 2021-06-17 | 51,877,002 | 359,457 | 64,146 | 99.19% | Passed |
Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year's compensation.
| Meeting year | Meeting date | Approval — company's computation |
|---|---|---|
| 2026 | 2026-06-17 | 95.91%a |
| 2025 | 2025-06-11 | 98.17%b |
| 2024 | 2024-06-12 | 98.74%c |
a. Approved under the standard stated in the filing — “Abstentions are considered votes present and entitled to vote on this proposal, and thus, will have the same effect as a vote "AGAINST" the proposal.”.
b. Approved under the standard stated in the filing — “Abstentions are considered votes present and entitled to vote on this proposal, and thus, will have the same effect as a vote "AGAINST" the proposal.”.
c. Approved under the standard stated in the filing — “Abstentions are considered votes present and entitled to vote on this proposal, and thus, will have the same effect as a vote "AGAINST" the proposal.”.
Approval percentages are the company's own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.
| Ratio (CEO : median employee) | — |
|---|---|
| CEO total compensation | — |
| Median employee compensation | — |
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| Richard H. SchellerIndependent | $45,000 | $67,364 | $10,661 | — | $100,000 | $223,025 |
| Mark AltmeyerIndependent | 65,522 | 46,781 | 10,661 | — | — | 122,964 |
| Errol De SouzaIndependent | 62,500 | 46,781 | 10,661 | — | — | 119,942 |
| Elizabeth GarofaloIndependent | 60,000 | 46,781 | 10,661 | — | — | 117,442 |
| Paula HammondIndependent | 57,500 | 46,781 | 10,661 | — | — | 114,942 |
| Kristine YaffeIndependent | 55,000 | 46,781 | 10,661 | — | — | 112,442 |
| David WehnerIndependent | 29,107 | 0 | 0 | — | — | 29,107 |
| Annual cash retainer | $45,000 |
|---|---|
| Annual equity retainer | — |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 10,000 / 7,500 / 5,000 |
| Stock ownership guideline | — |
| Component | FY2025 |
|---|---|
| Cash retainers and fees | $374,629 |
| Equity awards (grant-date value) | $301,269 |
| All other compensation | $100,000 |
| Total cost of the board | $775,898 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.
Of the companies Alector names as compensation peers, which name it back in their own disclosed peer groups. A peer set the market reciprocates reads differently from one selected in a single direction.
Reciprocity shown where the peer's own current proxy has been read — each mark is cited in the register to that peer's filing. A dash means the peer's current proxy was read and names no reciprocal group including Alector.
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | Assembly Biosciences, Inc. | 2025 | Jason Okazaki | $647,500 | $661,671 | $573,574 | $585,000 | $2,482,987 |
| 2 | Alector | 2025 | Arnon Rosenthal | 678,100 | 422,876 | 558,216 | 325,488 | 1,995,018 |
| 3 | Acumen Pharmaceuticals, Inc. | 2025 | Daniel O'Connell | 646,354 | 412,482 | 478,338 | 305,725 | 1,863,567 |
| 4 | Ovid Therapeutics Inc. | 2025 | Margaret Alexander | 515,000 | 24,806 | 118,466 | 350,000 | 1,022,272 |
| 5 | Boston | 2025 | Adam Peterson | 639,000 | 0 | 0 | 0 | 671,164 |
| — | Gain Therapeutics, Inc. | — | — | — | — | — | — | not in coverage universe |
Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
| Company | Annual incentive payout | Long-term vehicle mix | PSU measures include TSR | Compensation consultant |
|---|---|---|---|---|
| Alector | 80% | not disclosed | not disclosed | Pearl Meyer & Partners, LLC |
| Acumen Pharmaceuticals, Inc. | not disclosed | not disclosed | not disclosed | Aon |
| Assembly Biosciences, Inc. | not disclosed | Options 100 | No | Alpine Rewards, LLC |
| Boston | not disclosed | RSU 100 | not disclosed | not disclosed |
| Gain Therapeutics, Inc. | not disclosed | not disclosed | not disclosed | not disclosed |
| Ovid Therapeutics Inc. | not disclosed | not disclosed | not disclosed | Alpine Rewards, LLP |
Read from each company's Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company's filing does not state the item.
Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.
Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.
| # | Supports | Document | Filed | Accession | Location in document |
|---|---|---|---|---|---|
| 1 | Section 01, Arnon Rosenthal | DEF 14A | 2026-04-28 | 0001193125-26-186928 | Section “Executive Compensation”. As printed: 1,995,018. Filing ↗machine: span 1038665–1038674 |
| 2 | Section 01, Sara Kenkare-Mitra | DEF 14A | 2026-04-28 | 0001193125-26-186928 | Section “Executive Compensation”. As printed: 1,575,150. Filing ↗machine: span 1086879–1086888 |
| 3 | Section 01, Neil Berkley | DEF 14A | 2026-04-28 | 0001193125-26-186928 | Section “Executive Compensation”. As printed: 1,052,459. Filing ↗machine: span 1062790–1062799 |
| 4 | Section 03, Neil Berkley OPTION | DEF 14A | 2026-04-28 | 0001193125-26-186928 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t15 · r13 · c25 · span 1240874–1240881 |
| 5 | Section 03, Neil Berkley RSU | DEF 14A | 2026-04-28 | 0001193125-26-186928 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t15 · r10 · c25 · span 1212438–1212444 |
| 6 | Section 03, Arnon Rosenthal OPTION | DEF 14A | 2026-04-28 | 0001193125-26-186928 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t15 · r6 · c25 · span 1174204–1174211 |
| 7 | Section 03, Sara Kenkare RSU | DEF 14A | 2026-04-28 | 0001193125-26-186928 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t15 · r16 · c25 · span 1269647–1269653 |
| 8 | Section 03, Arnon Rosenthal OPTION | DEF 14A | 2026-04-28 | 0001193125-26-186928 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t15 · r4 · c25 · span 1155244–1155250 |
| 9 | Section 03, Arnon Rosenthal RSU | DEF 14A | 2026-04-28 | 0001193125-26-186928 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t15 · r7 · c25 · span 1183687–1183694 |
| 10 | Section 03, Arnon Rosenthal RSU | DEF 14A | 2026-04-28 | 0001193125-26-186928 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t15 · r5 · c25 · span 1164724–1164731 |
| 11 | Section 03, Neil Berkley OPTION | DEF 14A | 2026-04-28 | 0001193125-26-186928 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t15 · r11 · c25 · span 1221914–1221920 |
| 12 | Section 03, Neil Berkley OPTION | DEF 14A | 2026-04-28 | 0001193125-26-186928 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t15 · r9 · c25 · span 1202959–1202964 |
| 13 | Section 03, Sara Kenkare OPTION | DEF 14A | 2026-04-28 | 0001193125-26-186928 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t15 · r15 · c25 · span 1260159–1260165 |
| 14 | Section 03, Neil Berkley RSU | DEF 14A | 2026-04-28 | 0001193125-26-186928 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t15 · r12 · c25 · span 1231395–1231401 |
| 15 | Section 07, pay ratio | DEF 14A | 2026-04-28 | 0001193125-26-186928 | Section “CEO Pay Ratio”. As printed: —. Filing ↗ |
| 16 | Section 08, Richard H. Scheller | DEF 14A | 2026-04-28 | 0001193125-26-186928 | Section “Director Compensation”. As printed: 223,025. Filing ↗machine: t5 · r7 · c19 · span 362639–362848 |
| 17 | Section 08, Mark Altmeyer | DEF 14A | 2026-04-28 | 0001193125-26-186928 | Section “Director Compensation”. As printed: 122,964. Filing ↗machine: t5 · r3 · c18 · span 333960–334169 |
| 18 | Section 08, Errol De Souza | DEF 14A | 2026-04-28 | 0001193125-26-186928 | Section “Director Compensation”. As printed: 119,942. Filing ↗machine: t5 · r4 · c18 · span 341016–341225 |
| 19 | Section 08, Elizabeth Garofalo | DEF 14A | 2026-04-28 | 0001193125-26-186928 | Section “Director Compensation”. As printed: 117,442. Filing ↗machine: t5 · r5 · c18 · span 348075–348284 |
| 20 | Section 08, Paula Hammond | DEF 14A | 2026-04-28 | 0001193125-26-186928 | Section “Director Compensation”. As printed: 114,942. Filing ↗machine: t5 · r6 · c18 · span 355130–355339 |
| 21 | Section 08, Kristine Yaffe | DEF 14A | 2026-04-28 | 0001193125-26-186928 | Section “Director Compensation”. As printed: 112,442. Filing ↗machine: t5 · r9 · c18 · span 376813–377022 |
| 22 | Section 08, David Wehner | DEF 14A | 2026-04-28 | 0001193125-26-186928 | Section “Director Compensation”. As printed: 29,107. Filing ↗machine: t5 · r8 · c3 · span 364546–364754 |
| 23 | Section 02, Richard H. Scheller 2026-06-01 | Form 4 | 2026-06-03 | 0001193125-26-255990 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 24 | Section 02, Arnon Rosenthal 2026-06-02 | Form 4 | 2026-06-03 | 0001193125-26-255816 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 25 | Section 02, Neil Berkley 2026-06-02 | Form 4 | 2026-06-03 | 0001193125-26-255811 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 26 | Section 02, Grace Wong-Sarad 2026-06-02 | Form 4 | 2026-06-03 | 0001193125-26-255814 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 27 | Section 02, Grace Wong-Sarad 2026-06-03 | Form 4 | 2026-06-03 | 0001193125-26-255814 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 28 | Section 02, Mark Altmeyer 2026-06-17 | Form 4 | 2026-06-17 | 0001193125-26-274124 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 29 | Section 02, Elizabeth Garofalo 2026-06-17 | Form 4 | 2026-06-17 | 0001193125-26-274132 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 30 | Section 02, Paula Hammond 2026-06-17 | Form 4 | 2026-06-17 | 0001193125-26-274131 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 31 | Section 02, Richard H. Scheller 2026-06-17 | Form 4 | 2026-06-17 | 0001193125-26-274128 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 32 | Section 02, Richard H. Scheller 2026-06-17 | Form 4 | 2026-06-17 | 0001193125-26-274128 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 33 | Section 02, Kristine Yaffe 2026-06-17 | Form 4 | 2026-06-17 | 0001193125-26-274134 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 34 | Section 02, Louis J. Lavigne Jr 2026-06-17 | Form 4 | 2026-06-17 | 0001193125-26-274120 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 35 | Section 02, Louis J. Lavigne Jr 2026-06-17 | Form 4 | 2026-06-17 | 0001193125-26-274120 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 36 | Section 02, Errol B. Desouza 2026-06-17 | Form 4 | 2026-06-17 | 0001193125-26-274123 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 37 | Section 02, Errol B. Desouza 2026-06-17 | Form 4 | 2026-06-17 | 0001193125-26-274123 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 38 | Section 02, Mark Altmeyer 2026-06-17 | Form 4 | 2026-06-17 | 0001193125-26-274124 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 39 | Section 02, Elizabeth Garofalo 2026-06-17 | Form 4 | 2026-06-17 | 0001193125-26-274132 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 40 | Section 02, Paula Hammond 2026-06-17 | Form 4 | 2026-06-17 | 0001193125-26-274131 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 41 | Section 02, Kristine Yaffe 2026-06-17 | Form 4 | 2026-06-17 | 0001193125-26-274134 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 42 | Section 02, Grace Wong-Sarad 2026-07-09 | Form 4 | 2026-07-09 | 0001193125-26-299678 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 43 | Section 02, Arnon Rosenthal 2026-08-19 | Form 4 | 2026-08-21 | 0001193125-26-361376 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 44 | Section 02, Arnon Rosenthal 2026-08-19 | Form 4 | 2026-08-21 | 0001193125-26-361376 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 45 | Section 02, Arnon Rosenthal 2026-08-19 | Form 4 | 2026-08-21 | 0001193125-26-361376 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 46 | Section 02, Arnon Rosenthal 2026-08-19 | Form 4 | 2026-08-21 | 0001193125-26-361376 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 47 | Section 02, Grace Wong-Sarad 2026-09-02 | Form 4 | 2026-09-04 | 0001193125-26-383858 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 48 | Section 02, Grace Wong-Sarad 2026-09-03 | Form 4 | 2026-09-04 | 0001193125-26-383858 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 49 | Section 02, Arnon Rosenthal 2026-09-03 | Form 4 | 2026-09-04 | 0001193125-26-383857 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 50 | Section 02, Neil Berkley 2026-09-03 | Form 4 | 2026-09-04 | 0001193125-26-383856 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 51 | Section 02, Grace Wong-Sarad 2026-09-04 | Form 4 | 2026-09-04 | 0001193125-26-383858 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 52 | Section 02, Arnon Rosenthal 2026-10-13 | Form 4 | 2026-10-15 | 0001193125-26-422869 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 53 | Section 02, Arnon Rosenthal 2026-10-13 | Form 4 | 2026-10-15 | 0001193125-26-422869 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 54 | Section 02, Arnon Rosenthal 2026-10-13 | Form 4 | 2026-10-15 | 0001193125-26-422869 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 55 | Section 02, Arnon Rosenthal 2026-10-13 | Form 4 | 2026-10-15 | 0001193125-26-422869 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 56 | Section 02, Arnon Rosenthal 2026-10-13 | Form 4 | 2026-10-15 | 0001193125-26-422869 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 57 | Section 02, Arnon Rosenthal 2026-10-13 | Form 4 | 2026-10-15 | 0001193125-26-422869 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 58 | Section 02, Arnon Rosenthal 2026-10-13 | Form 4 | 2026-10-15 | 0001193125-26-422869 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 59 | Section 02, Arnon Rosenthal 2026-10-13 | Form 4 | 2026-10-15 | 0001193125-26-422869 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 60 | Section 02, Arnon Rosenthal 2026-10-13 | Form 4 | 2026-10-15 | 0001193125-26-422869 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 61 | Section 02, Arnon Rosenthal 2026-10-13 | Form 4 | 2026-10-15 | 0001193125-26-422869 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 62 | Section 02, Arnon Rosenthal 2026-10-13 | Form 4 | 2026-10-15 | 0001193125-26-422869 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 63 | Section 02, Arnon Rosenthal 2026-10-13 | Form 4 | 2026-10-15 | 0001193125-26-422869 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 64 | Section 02, Arnon Rosenthal 2026-10-13 | Form 4 | 2026-10-15 | 0001193125-26-422869 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 65 | Section 02, Arnon Rosenthal 2026-10-13 | Form 4 | 2026-10-15 | 0001193125-26-422869 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 66 | Section 02, Grace Wong-Sarad 2026-10-13 | Form 4 | 2026-10-15 | 0001193125-26-422867 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 67 | Section 02, Grace Wong-Sarad 2026-10-13 | Form 4 | 2026-10-15 | 0001193125-26-422867 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 68 | Section 02, Grace Wong-Sarad 2026-10-13 | Form 4 | 2026-10-15 | 0001193125-26-422867 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 69 | Section 02, Grace Wong-Sarad 2026-10-13 | Form 4 | 2026-10-15 | 0001193125-26-422867 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 70 | Section 02, Grace Wong-Sarad 2026-10-13 | Form 4 | 2026-10-15 | 0001193125-26-422867 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 71 | Section 02, Grace Wong-Sarad 2026-10-13 | Form 4 | 2026-10-15 | 0001193125-26-422867 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 72 | Section 02, Grace Wong-Sarad 2026-10-13 | Form 4 | 2026-10-15 | 0001193125-26-422867 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 73 | Section 02, Grace Wong-Sarad 2026-10-13 | Form 4 | 2026-10-15 | 0001193125-26-422867 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 74 | Section 02, Grace Wong-Sarad 2026-10-13 | Form 4 | 2026-10-15 | 0001193125-26-422867 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 75 | Section 02, Grace Wong-Sarad 2026-10-13 | Form 4 | 2026-10-15 | 0001193125-26-422867 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 76 | Section 02, Grace Wong-Sarad 2026-10-13 | Form 4 | 2026-10-15 | 0001193125-26-422867 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 77 | Section 02, Grace Wong-Sarad 2026-10-13 | Form 4 | 2026-10-15 | 0001193125-26-422867 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 78 | Section 02, Arnon Rosenthal 2026-10-14 | Form 4 | 2026-10-15 | 0001193125-26-422869 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 79 | Section 02, Arnon Rosenthal 2026-10-14 | Form 4 | 2026-10-15 | 0001193125-26-422869 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 80 | Section 02, Neil Berkley 2026-10-14 | Form 4 | 2026-10-15 | 0001193125-26-422868 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 81 | Section 02, Neil Berkley 2026-10-14 | Form 4 | 2026-10-15 | 0001193125-26-422868 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 82 | Section 02, Grace Wong-Sarad 2026-10-14 | Form 4 | 2026-10-15 | 0001193125-26-422867 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 83 | Section 02, Grace Wong-Sarad 2026-10-14 | Form 4 | 2026-10-15 | 0001193125-26-422867 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 84 | Section 06, 2026 vote | Form 8-K | 2026-06-17 | 0001193125-26-274130 | Item 5.07 · say-on-pay result. As reported: 95.91% (votes for as printed: 58,652,335). Filing ↗ |
| 85 | Section 06, 2025 vote | Form 8-K | 2025-06-13 | 0001193125-25-140731 | Item 5.07 · say-on-pay result. As reported: 98.17% (votes for as printed: 68,738,538). Filing ↗ |
| 86 | Section 06, 2024 vote | Form 8-K | 2024-06-12 | 0000950170-24-072512 | Item 5.07 · say-on-pay result. As reported: 98.74% (votes for as printed: 72,009,466). Filing ↗ |
| 87 | Section 01 trend, Δ column (computed) | Computed | — | — | Δ = current-FY total − prior-FY total per named officer.machine: formula: Δ = FY(n) − FY(n−1) |
| 88 | Section 03b vehicle mix (computed) | Computed | — | — | RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).machine: formula: sums + PSU ratio |
| 89 | Section 09b board cost (computed) | Computed | — | — | Cash 374,629 + equity 301,269 + all other 100,000 = 775,898, summed across the director compensation table rows.machine: formula: Σ = 775,898 |
| 90 | Assembly Biosciences, Inc., Section 10b CEO total | DEF 14A | 2026-04-22 | 0001193125-26-170417 | CEO total compensation as printed in Assembly Biosciences, Inc.'s own proxy. As printed: 2,482,987. Filing ↗machine: t38 · r2 · c25 · span 1134174–1134183 |
| 91 | Alector (subject), Section 10b CEO total | DEF 14A | 2026-04-28 | 0001193125-26-186928 | CEO total compensation as printed in Alector's own proxy. As printed: 1,995,018. Filing ↗machine: span 1038665–1038674 |
| 92 | Acumen Pharmaceuticals, Inc., Section 10b CEO total | DEF 14A | 2026-04-23 | 0001628280-26-026870 | CEO total compensation as printed in Acumen Pharmaceuticals, Inc.'s own proxy. As printed: 1,863,567. Filing ↗machine: r2 · c48 · span 390272–390281 |
| 93 | Ovid Therapeutics Inc., Section 10b CEO total | DEF 14A | 2026-04-27 | 0001628280-26-027621 | CEO total compensation as printed in Ovid Therapeutics Inc.'s own proxy. As printed: 1,022,272. Filing ↗machine: r4 · c42 · span 259572–259581 |
| 94 | Boston, Section 10b CEO total | DEF 14A | 2026-07-01 | 0001437749-26-022287 | CEO total compensation as printed in Boston's own proxy. As printed: 671,164. Filing ↗ |
| 95 | Section 10a, Assembly Biosciences, Inc. reciprocity | DEF 14A | — | 0001193125-26-170417 | Assembly Biosciences, Inc.'s most recent proxy was read; its disclosed peer group does not include Alector. Filing ↗ |
The Pay Desk — the free weekly executive pay briefing, one company at a time, every number traceable to a public filing.
You'll confirm on The Pay Desk's sign-up page.